From the multi-center MAQI consortium, the authors explored the increased risk of bleeding when patients who were prescribed DOAC medications also were taking aspirin therapy.
Learn more about how the data was collected, how the analyses were conducted, and what steps are being taken to reduce unnecessary aspirin use in order to try and reduce bleeding complications.
Jordan Schaefer, MD
Geoffrey Barnes, MD, MSc
Arthur Allen, PharmD, CACP
Tracy Minichiello, MD
Link to Article: https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2778963
We are pleased to provide enduring accreditation for this webinar!